Uni-Bio Science Group Announces 2020 Interim Results
- Written by Reporters
Operating Profit From Marketed Pharmaceutical Products Recorded an Increase of 126.6%
Expanding R&D Activity in Antibody Drug Development to Diversify Product Portfolio
HONG KONG, CHINA - EQS Newswire - 28 August 2020 - A fully integrated biopharmaceutical company -- Uni-Bio Science Group Limited ("Uni-Bio Science", together with...
Read more: Uni-Bio Science Group Announces 2020 Interim Results

